ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,463.54
      0.08%
      US Tech 100
      18,493.20
      -0.14%
      Dow Jones
      40,539.93
      -0.12%
      Brent Oil
      78.895
      -0.32%
      Bitcoin
      66,347.82
      -0.71%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Sangamo Therapeutics Inc (SGMO)

      7. Sangamo Therapeutics Inc (SGMO) Financials

      Sangamo Therapeutics Inc

      Sangamo Therapeutics Inc (SGMO)

      NASDAQ
      0.9167
      0.0518
      (5.99%)
      Closed July 29 4:00PM
      Delayed by 15 minutes
      0.92
      0.0033
      (0.36%)
      After Hours: 7:59PM
      Delayed by 15 minutes

      Sangamo Therapeutics Inc Financial Summary

      The current SGMO market cap is 190.91M. The company's latest EPS is USD -1.2425 and P/E is -0.73.

      Income Statement

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 157.96M6.84M9.4M2.04M481k
      Operating Income 38.47M-123.57M-61.61M-67.1M-47.18M
      Net Income 21.13M-114.51M-104.16M-60.3M-49.09M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 102.43M118.19M110.7M111.3M176.23M
      Operating Income -105.18M-129.55M-183.34M-201.28M-208.48M
      Net Income -95.19M-121M-178.29M-192.28M-257.83M

      Balance Sheet

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 440.57M325.07M219.7M165.32M128.96M
      Total Liabilities 104.96M91.43M84.78M82.43M72.26M
      Total Equity 335.61M233.64M134.92M82.89M56.7M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 637.52M938.55M721.92M562.51M165.32M
      Total Liabilities 204.78M441.18M346.58M267.55M82.43M
      Total Equity 432.74M497.37M375.34M294.96M82.89M

      Cash Flow

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -66.3M-127.01M-174.3M-224.84M-48.66M
      Investing 35.73M78.2M115.82M153.53M35.84M
      Financing 8M14.52M14.42M14.59M22.12M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -144.4M169.88M-233.25M-223.63M-224.84M
      Investing -59.8M-271.63M248.2M59.29M153.53M
      Financing 142.03M153.1M32.86M84.66M14.59M

      Stats and Ratios

      Market Cap 190.91M
      Price to Earnings Ratio -0.73
      Price to Sales Ratio 1.07
      Price to Cash Ratio 4.18
      Price to Book Ratio 2.28
      Dividend Yield -

      Share Statistics

      Shares Outstanding 207.51M
      Average Volume (1 week) 86.37M
      Average Volume (1 Month) 24.38M
      52 Week Change -30.83%
      52 Week High 1.48
      52 Week Low 0.2911
      Spread (Intraday) 0.01 (0.65%)

      Company Info

      Company Name Sangamo Therapeutics Inc
      Address 1209 orange street
      wilmington, delaware 19801
      Website https://www.sangamo.com
      Industry biological pds,ex diagnstics (2836)